Clinical Trials · NCT07811895

Dual GIP/GLP-1 Receptor Agonist in Obese Women Before Frozen Embryo Transfer

Not Yet RecruitingN/ATirzepatide (Investigational)
Phase
N/A
Recruitment status
Not Yet Recruiting
Sponsor
RenJi Hospital
Enrollment
1,510
Start date
Sep 2026
Locations
1 site, China
Primary endpoint
Good birth outcome rate
View Tirzepatide compound reference